Preclinical CRO market to grow by USD 2,253.55 million from 2022 to 2027|The increasing number of clinical trials drives growth - Technavio

NEW YORK, Aug. 3, 2023 /PRNewswire/ -- The preclinical CRO market size is expected to increase by USD 2,253.55 million from 2022 to 2027, registering a CAGR of 7.71%, according to the latest research report from Technavio. Discover Life Sciences Tools & Services industry potential and make informed business decisions based on qualitative and quantitative evidence highlighted in Technavio reports. View Sample Report!

The preclinical CRO market covers the following areas:

• Preclinical CRO Market Sizing
• Preclinical CRO Market Forecast
• Preclinical CRO Market Analysis

Company Landscape

The global preclinical CRO market is fragmented, with the presence of various vendors in the market. The vendors in the market in focus compete in terms of price, delivery speed, reliability, supply chain capacity, and others. With the growth in clinical research in most regions across the world, the need for preclinical CRO services is increasing. The preclinical cro market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Company Offerings

• Altasciences - The company offers preclinical CRO such as in vivo GLP and non-GLP preclinical services.
• AmplifyBio - The company offers preclinical CRO such as general toxicology, bioanalytics, and Inhalation toxicology.
• Charles River Laboratories International Inc. - The company offers preclinical CRO such as toxicology services, pathology services, and laboratory services.

For the market's vendor landscape highlights with a comprehensive list of vendors and their offerings - View Sample in a minutes

Key Market Segmentation

Technavio has segmented the market into End-User (pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes), Service (toxicology testing, bioanalysis and DMPK studies, compound management, and others), and Geography (North America, Europe, Asia, and the Rest of the World (ROW)).

• The pharmaceutical and biopharmaceutical companies segment will be significant during the forecast period. Pharmaceutical and biopharmaceutical companies provide resources and then outsource the research effort to CROs in both clinical and commercial-stage manufacturing due to recognizing the benefits of collaboration. The benefits include meeting the ever-increasing demand for generic drugs and biologics while also ensuring no compromise on the capital-intensive nature of the industry. Hence, such factors boost the growth of the segment in focus during the forecast period.

View Sample Report in minutes for more highlights into the market segments.

Regional Market Outlook

• North America will contribute 41% to the growth of the global market during the forecast period. Owing to its advanced healthcare infrastructure, with IQVIA, the world's largest CRO, being headquartered in the US, the region had the largest share of the global preclinical CRO market in 2022. These companies provide contract research solutions and innovative technology services. Hence, such factors boost the regional market growth during the forecast period.

For more key highlights on the regional market share of most of the above-mentioned countries.- View Sample Report

Companies Mentioned

• Altasciences
• AmplifyBio
• BioEmission Technology Solutions
• Charles River Laboratories International Inc.
• CYNBIOSE
• Eurofins Scientific SE
• Gempharmatech Co. Ltd.
• Global Center for Medical Innovation
• ICON plc
• Imavita S.A.S.
• IQVIA Inc.
• JSR Corp.
• Kunming Biomed International Ltd.
• Laboratory Corp. of America Holdings
• Medpace Holdings Inc.
• Parexel International Corp.
• Thermo Fisher Scientific Inc.
• Veeda Clinical Research Ltd.
• WuXi AppTec Co. Ltd.
• Vivotecnia

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - Buy the report!

Market Dynamics

The increasing number of clinical trials is an emerging preclinical CRO market trend. Development and research are required through more effective funding of clinical trials. Government initiatives, including funding clinical trials of drug manufacturers and training of clinical trial staff are conducted in regional markets, helping ensure the reduction of errors and the safety and efficacy of products. Hence, such factors are likely to contribute to the growth of the global preclinical CRO market during the forecast period.

Intellectual property issues are key challenges that impede the growth of the market. To outsource medical research but intellectual property issues are hindering the growth of the market, CROs provide the option for pharmaceutical, biotechnology, and medical device industries. Pharmaceutical companies that manufacture new drugs and medications must also provide data on the safety and efficacy as per the relevant government and regulatory agency-framed rules and regulations. Hence, such challenges impede market growth during the forecast period.

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:
The veterinary CRO market size is expected to increase to USD 277.21 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.75%. Furthermore, this report extensively covers veterinary contract research organization market segmentation by type (clinical trials, toxicology, and market authorization and regulatory support) and geography (North America, Europe, Asia, and Rest of World (ROW)). One of the key factors driving the global veterinary CRO market growth is the increase in ownership of companion animals. 

The Global Contract Research Organization (CRO) Market size is estimated to grow by USD 52.46 billion between 2022 and 2027 accelerating at a CAGR of 11.75% during the forecast period. This contract research organization market research report extensively covers market segmentation by application (clinical research, early phase development, laboratory, and regulatory consulting), end-user (pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes), and geography (North America, Europe, Asia, and Rest of World (ROW)). One of the key factors driving the CRO market is the growth of the biopharmaceutical industry.

Key Topics Covered:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Service
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global preclinical CRO market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on global preclinical cro market 2017 - 2021 ($ million)

• 4.2 End-user Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.3 Service Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Service Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments 
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)

• 6.4 Medical device companies - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Medical device companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Medical device companies - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%)

• 6.5 Academic institutes - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Academic institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Academic institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by End-user 
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Service

• 7.1 Market segments 
• Exhibit 48: Chart on Service - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Service - Market share 2022-2027 (%)

• 7.2 Comparison by Service 
• Exhibit 50: Chart on Comparison by Service
• Exhibit 51: Data Table on Comparison by Service

• 7.3 Toxicology testing - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%)

• 7.4 Bioanalysis and DMPK studies - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%)

• 7.5 Compound management - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Compound management - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Compound management - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Compound management - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Compound management - Year-over-year growth 2022-2027 (%)

• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.7 Market opportunity by Service 
• Exhibit 68: Market opportunity by Service ($ million)
• Exhibit 69: Data Table on Market opportunity by Service ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 71: Chart on Market share by geography 2022-2027 (%)
• Exhibit 72: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.11 China - Market size and forecast 2022-2027
• Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 111: Market opportunity by geography ($ million)
• Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 115: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 117: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 118: Matrix on vendor position and classification

• 12.3 Altasciences 
• Exhibit 119: Altasciences - Overview
• Exhibit 120: Altasciences - Product / Service
• Exhibit 121: Altasciences - Key offerings

• 12.4 AmplifyBio 
• Exhibit 122: AmplifyBio - Overview
• Exhibit 123: AmplifyBio - Product / Service
• Exhibit 124: AmplifyBio - Key offerings

• 12.5 Charles River Laboratories International Inc.
• Exhibit 125: Charles River Laboratories International Inc. - Overview
• Exhibit 126: Charles River Laboratories International Inc. - Business segments
• Exhibit 127: Charles River Laboratories International Inc. - Key news
• Exhibit 128: Charles River Laboratories International Inc. - Key offerings
• Exhibit 129: Charles River Laboratories International Inc. - Segment focus

• 12.6 Eurofins Scientific SE 
• Exhibit 130: Eurofins Scientific SE - Overview
• Exhibit 131: Eurofins Scientific SE - Business segments
• Exhibit 132: Eurofins Scientific SE - Key news
• Exhibit 133: Eurofins Scientific SE - Key offerings
• Exhibit 134: Eurofins Scientific SE - Segment focus

• 12.7 ICON plc 
• Exhibit 135: ICON plc - Overview
• Exhibit 136: ICON plc - Product / Service
• Exhibit 137: ICON plc - Key offerings

• 12.8 Imavita S.A.S. 
• Exhibit 138: Imavita S.A.S. - Overview
• Exhibit 139: Imavita S.A.S. - Product / Service
• Exhibit 140: Imavita S.A.S. - Key offerings

• 12.9 IQVIA Inc. 
• Exhibit 141: IQVIA Inc. - Overview
• Exhibit 142: IQVIA Inc. - Business segments
• Exhibit 143: IQVIA Inc. - Key news
• Exhibit 144: IQVIA Inc. - Key offerings
• Exhibit 145: IQVIA Inc. - Segment focus

• 12.10 JSR Corp. 
• Exhibit 146: JSR Corp. - Overview
• Exhibit 147: JSR Corp. - Business segments
• Exhibit 148: JSR Corp. - Key offerings
• Exhibit 149: JSR Corp. - Segment focus

• 12.11 Kunming Biomed International Ltd.
• Exhibit 150: Kunming Biomed International Ltd. - Overview
• Exhibit 151: Kunming Biomed International Ltd. - Product / Service
• Exhibit 152: Kunming Biomed International Ltd. - Key offerings

• 12.12 Laboratory Corp. of America Holdings
• Exhibit 153: Laboratory Corp. of America Holdings - Overview
• Exhibit 154: Laboratory Corp. of America Holdings - Business segments
• Exhibit 155: Laboratory Corp. of America Holdings - Key news
• Exhibit 156: Laboratory Corp. of America Holdings - Key offerings
• Exhibit 157: Laboratory Corp. of America Holdings - Segment focus

• 12.13 Medpace Holdings Inc. 
• Exhibit 158: Medpace Holdings Inc. - Overview
• Exhibit 159: Medpace Holdings Inc. - Product / Service
• Exhibit 160: Medpace Holdings Inc. - Key offerings

• 12.14 Thermo Fisher Scientific Inc. 
• Exhibit 161: Thermo Fisher Scientific Inc. - Overview
• Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 163: Thermo Fisher Scientific Inc. - Key news
• Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus

• 12.15 Veeda Clinical Research Ltd. 
• Exhibit 166: Veeda Clinical Research Ltd. - Overview
• Exhibit 167: Veeda Clinical Research Ltd. - Product / Service
• Exhibit 168: Veeda Clinical Research Ltd. - Key offerings

• 12.16 Vivotecnia 
• Exhibit 169: Vivotecnia - Overview
• Exhibit 170: Vivotecnia - Product / Service
• Exhibit 171: Vivotecnia - Key offerings

• 12.17 WuXi AppTec Co. Ltd. 
• Exhibit 172: WuXi AppTec Co. Ltd. - Overview
• Exhibit 173: WuXi AppTec Co. Ltd. - Business segments
• Exhibit 174: WuXi AppTec Co. Ltd. - Key offerings
• Exhibit 175: WuXi AppTec Co. Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 176: Inclusions checklist
• Exhibit 177: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 178: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 179: Research methodology
• Exhibit 180: Validation techniques employed for market sizing
• Exhibit 181: Information sources

• 13.5 List of abbreviations 
• Exhibit 182: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio